Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Colorcon
Chinese Patent Office
Federal Trade Commission
Johnson and Johnson
US Department of Justice
Novartis
Fish and Richardson
Medtronic

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,703,181

« Back to Dashboard

Summary for Patent: 8,703,181
Title:Liposomes useful for drug delivery
Abstract: The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provides methods of making the liposome compositions provided by the present invention.
Inventor(s): Hong; Keelung (San Francisco, CA), Drummond; Daryl C. (Pacifica, CA), Kirpotin; Dmitri (San Francisco, CA)
Assignee: Merrimack Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:13/654,373
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Delivery; Formulation;

Drugs Protected by US Patent 8,703,181

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Ipsen Inc ONIVYDE irinotecan hydrochloride INJECTABLE, LIPOSOMAL;IV (INFUSION) 207793-001 Oct 22, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF PANCREATIC CANCER ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,703,181

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,717,723 Liposomes useful for drug delivery ➤ Subscribe
8,147,867 Liposomes useful for drug delivery ➤ Subscribe
9,737,528 Liposomes useful for drug delivery to the brain ➤ Subscribe
8,329,213 Liposomes useful for drug delivery ➤ Subscribe
9,724,303 Liposomes useful for drug delivery ➤ Subscribe
8,992,970 Liposomes useful for drug delivery ➤ Subscribe
8,658,203 Liposomes useful for drug delivery to the brain ➤ Subscribe
9,730,891 Liposomes useful for drug delivery ➤ Subscribe
9,782,349 Liposomes useful for drug delivery ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,703,181

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 86063 ➤ Subscribe
Taiwan I359029 ➤ Subscribe
Taiwan 200605908 ➤ Subscribe
Russian Federation 2015155368 ➤ Subscribe
Russian Federation 2011112461 ➤ Subscribe
Russian Federation 2424792 ➤ Subscribe
Russian Federation 2006142766 ➤ Subscribe
Portugal 1746976 ➤ Subscribe
Poland 1746976 ➤ Subscribe
Norway 20065532 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
Cipla
Healthtrust
UBS
Fuji
Chinese Patent Office
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot